Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Renovaro Biosciences ( (RENB) ) has shared an announcement.
Renovaro Inc. received a notice from Nasdaq on July 7, 2025, for failing to comply with the requirement to hold an annual meeting of shareholders within a year after the fiscal year ended June 30, 2024. The company has 45 days to submit a compliance plan, and if accepted, could receive an extension until December 29, 2025. While the notice does not immediately affect the company’s stock listing, failure to comply may lead to delisting.
More about Renovaro Biosciences
Average Trading Volume: 3,550,025
Technical Sentiment Signal: Sell
Current Market Cap: $46.47M
Learn more about RENB stock on TipRanks’ Stock Analysis page.